Otsuka Holdings Co., Ltd., through its subsidiaries, operates in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of central nervous system disorders, oncology, cardiovascular-renal, infectious disease, dermatological disease, gastroenterology, ophthalmology, diagnostics, surgical aid and regenerative, allergy/immunology, and urology. It also provides EQUELLE, a food product for women's health; BODYMAINTÉ Jelly, a conditioning food product; POCARI SWEAT, an electrolyte drink; Calorie Mate, a nutritional food product; SOYJOY, a soy bar; OS-1, an oral rehydration solution; HINE E-GEL, a concentrated liquid diet; PROCESSLEAD, a chew and swallow managing food product; REHADAYS, a beverage to support exercise and rehabilitation; Oronine H Ointment, a household antiseptic medicine; and vitamin tonics, herbal digestive drinks, and herbal crude drugs. In addition, the company offers soft drinks, foods, and wines; chemical materials for automotive, electrical, electronic, and building materials sectors; electronic equipment; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards and board arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; business information consultancy services; caps and ports for containers; and hydrazine. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone81 3 6717 1410
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees32,935
Next Earnings DateN/A
OptionableNot Optionable
OTSUKA HOLDINGS/ADR (OTCMKTS:OTSKY) Frequently Asked Questions
What is OTSUKA HOLDINGS/ADR's stock symbol?
OTSUKA HOLDINGS/ADR trades on the OTCMKTS under the ticker symbol "OTSKY."
What guidance has OTSUKA HOLDINGS/ADR issued on next quarter's earnings?
OTSUKA HOLDINGS/ADR issued an update on its FY 2019 earnings guidance on Wednesday, February, 13th. The company provided EPS guidance of $1.85-1.85 for the period. The company issued revenue guidance of $12.649 billion.
Has OTSUKA HOLDINGS/ADR been receiving favorable news coverage?
News coverage about OTSKY stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. OTSUKA HOLDINGS/ADR earned a news impact score of 1.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the next few days.
Who are some of OTSUKA HOLDINGS/ADR's key competitors?
Some companies that are related to OTSUKA HOLDINGS/ADR include AstraZeneca (AZN), GlaxoSmithKline (GSK), Bayer (BAYN), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY) and Vita Life Sciences (VLS).
What other stocks do shareholders of OTSUKA HOLDINGS/ADR own?
Who are OTSUKA HOLDINGS/ADR's key executives?
OTSUKA HOLDINGS/ADR's management team includes the folowing people:
- Mr. Tatsuo Higuchi, Pres, CEO & Representative Director (Age 69)
- Yuko Makino, CFO & Director
- Mr. Yoshiro Matsuo, Sr. MD of Admin. & Director (Age 59)
- Noriko Tojo, Exec. Director
- Mr. Sadanobu Tobe, Exec. Director (Age 78)
How do I buy shares of OTSUKA HOLDINGS/ADR?
Shares of OTSKY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is OTSUKA HOLDINGS/ADR's stock price today?
One share of OTSKY stock can currently be purchased for approximately $17.50.
What is OTSUKA HOLDINGS/ADR's official website?
How can I contact OTSUKA HOLDINGS/ADR?
The company can be reached via phone at 81 3 6717 1410.
MarketBeat Community Rating for OTSUKA HOLDINGS/ADR (OTCMKTS OTSKY)
MarketBeat's community ratings are surveys of what our community members think about OTSUKA HOLDINGS/ADR and other stocks. Vote "Outperform" if you believe OTSKY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OTSKY will underperform the S&P 500 over the long term. You may vote once every thirty days.
